Who is sponsoring NCT03893292?

NCT03893292 is sponsored by Hospital for Special Surgery, New York.

What condition does NCT03893292 study?

NCT03893292 studies Postoperative Pain, Knee Osteoarthritis.

What drugs are being tested in NCT03893292?

Interventions: Total knee replacement, COOLIEF.

What is the status of NCT03893292?

NCT03893292 is currently WITHDRAWN.

Last reviewed 2020-11-13 · How we verify

Preop Cooled Radiofrequency Ablation for Total Knee Replacement

NCT03893292 WITHDRAWN

Total knee replacement surgery is commonly performed for patients suffering from severe knee osteoarthritis. However, 20% of patients continue to experience pain after surgery. There is currently no standardized pain management protocol for pain after total knee replacement. Cooled radiofrequency ablation has been used successfully to alleviate spin-related pain and has recently been approved by the FDA to treat chronic knee arthritic pain. This pilot study aims to collect preliminary data on the use of cooled radiofrequency ablation in patients undergoing total knee replacement.

Details

Lead sponsor	Hospital for Special Surgery, New York
Status	WITHDRAWN
Start date	Thu Jan 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Oct 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Postoperative Pain
Knee Osteoarthritis

Interventions

Total knee replacement
COOLIEF

Countries

United States